Comparing the effectivity of two different pneumococcal vaccines against severe pneumococcal diseases in adult kidney and liver transplant patients
Active, not recruiting
- Conditions
- Immunogenicity of pneumococcal vaccines in liver and kidney transplant patientsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
- Registration Number
- EUCTR2012-002657-30-FI
- Lead Sponsor
- HYKS-instituutti
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Consecutive adult (>18 years) liver and kidney transplant patients are enrolled as they enter the transplant waiting list
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 125
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 25
Exclusion Criteria
Age< 18 years
Previous Pneumococcal vaccination < 3 years ago
Febrile illness at the time of vaccination
Any sign of graft failure or rejection at the time of vaccination
Splenectomy
Pregnancy
Critically ill patient due to any cause, including terminal uncompensated liver disease
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method